scholarly journals Manifestation of Subclinical Diabetes Insipidus due to Pituitary Tumor during Pregnancy.

1996 ◽  
Vol 43 (5) ◽  
pp. 577-583 ◽  
Author(s):  
MASAMI HASHIMOTO ◽  
TOSHIO OGURA ◽  
FUMIO OTSUKA ◽  
TAKAYOSHI YAMAUCHI ◽  
YUKARI MIMURA ◽  
...  
Keyword(s):  
Diabetes Insipidus ◽  
Pituitary Tumor ◽  
Subclinical Diabetes

Acromegaly with Diabetes Insipidus after Pituitary Tumor Removal: Successful Pregnancy and Delivery

2010 ◽  
Vol 25 (1) ◽  
pp. 56
Author(s):  
Sei-Hyun Kim ◽  
Joo Il Kim ◽  
Yae Min Park ◽  
In Sik Won ◽  
Kwen-Chul Shin ◽  
...  
Keyword(s):  
Diabetes Insipidus ◽  
Pituitary Tumor ◽  
Tumor Removal ◽  
Successful Pregnancy ◽  
Pregnancy And Delivery

Aggravation of subclinical diabetes insipidus during pregnancy

1992 ◽  
Vol 37 (2) ◽  
pp. 154-154
Author(s):  
Y Iwasaki ◽  
Y Oiso ◽  
K Kondo ◽  
S Takagi ◽  
K Takatsuki ◽  
...  
Keyword(s):  
Diabetes Insipidus ◽  
Subclinical Diabetes

Central Diabetes Insipidus in a Dog With a Pro-Opiomelanocortin-Producing Pituitary Tumor ot Causing Hyperadrenocorticism

1995 ◽  
Vol 9 (5) ◽  
pp. 361-365 ◽  
Author(s):  
Mariëlle M.C. Goossens ◽  
Ad Rijnberk ◽  
Jan A. Mol ◽  
Jeannette Wolfswinkel ◽  
George Voorhout
Keyword(s):  
Diabetes Insipidus ◽  
Pituitary Tumor ◽  
Central Diabetes Insipidus

scholarly journals Incidence of central diabetes insipid us among the patients undergoing pituitary tumor surgery 06 through trans-sphenoidal approach

2019 ◽  
Vol 21 (1) ◽  
pp. 6-10
Author(s):  
KMT Islam ◽  
S Alam ◽  
R Amin ◽  
M Haque ◽  
HD Nath ◽  
...  
Keyword(s):  
Diabetes Insipidus ◽  
Pituitary Tumor ◽  
Kidney Diseases ◽  
Signs And Symptoms ◽  
Pituitary Surgery ◽  
Pituitary Tumour ◽  
Electrolyte Imbalance ◽  
Tumor Surgery ◽  
Cross Sectional ◽  
Postoperative Serum

Background: Diabetes insipidus (DI) is a common complication following pituitary surgery. Thiscondition can be transient or permanent and the signs and symptoms of this disorder can bemimicked by the normal postoperative course. Objective: This study was carried out to find out the incidence of central diabetes insipidus (DI)among the patients undergoing pituitary tumor surgery through trans-sphenoidal approach eitherendoscopic or microsurgical for the first time.Study Design: Cross sectional observational study Methods: Patients with central (Neurogenic) diabetes insipidus prior to surgery, co-morbiditieslike diabetes mellitus, kidney diseases, electrolyte imbalance, recurrent cases were excludedfrom this study. Patients were followed up to 7th postoperative day by recording and analyzingfindings of postoperative serum electrolytes, urinary specific gravity, hourly urinary volume forestablishing diabetes insipid us. Results: 76.9% of patients developed diabetes insipidus and 70.0% of patients did not developdiabetes insipid us those who underwent pituitary tumour surgery by trans-sphenoidal endoscopicapproach; 23.1% of patients developed diabetes insipid us and 30.0% of patients did not developdiabetes insipid us those who underwent pituitary tumour surgery by trans-sphenoidal mlcrosurgicalapproach. Conclusion: Prediction of DI help us in pre-operative counseling and post-operative managementof the patients as well as to reduce complications related morbidity after pituitary tumor surgery. Journal of Surgical Sciences (2017) Vol. 21 (1) :6-10

Repeat Serum Sodium Values over 145 Predict Diabetes Insipidus after Endoscopic Transphenoidal Pituitary Tumor Resection

2020 ◽  
Author(s):  
Rebecca Breese ◽  
Avinash Chandran ◽  
Sebastian Gil ◽  
Weston Northam ◽  
Elizabeth Harris ◽  
...  
Keyword(s):  
Diabetes Insipidus ◽  
Serum Sodium ◽  
Pituitary Tumor ◽  
Tumor Resection

Aggravation of Subclinical Diabetes Insipidus during Pregnancy

1991 ◽  
Vol 324 (8) ◽  
pp. 522-526 ◽  
Author(s):  
Yasumasa Iwasaki ◽  
Yutaka Oiso ◽  
Kunikazu Kondo ◽  
Shinko Takagi ◽  
Kensuke Takatsuki ◽  
...  
Keyword(s):  
Diabetes Insipidus ◽  
Subclinical Diabetes

Withholding Perioperative Steroids in Patients Undergoing Transsphenoidal Resection for Pituitary Disease: Randomized Prospective Clinical Trial to Assess Safety

Neurosurgery ◽  
2018 ◽  
Vol 85 (2) ◽  
pp. E226-E232 ◽  
Author(s):  
Karin Sterl ◽  
Bithika Thompson ◽  
Charles W Goss ◽  
Ralph G Dacey ◽  
Keith M Rich ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Postoperative Complications ◽  
Diabetes Insipidus ◽  
Hospital Stay ◽  
Adrenal Insufficiency ◽  
Hpa Axis ◽  
Pituitary Tumor ◽  
Transsphenoidal Surgery ◽  
Cortisol Levels ◽  
Transsphenoidal Resection

Abstract BACKGROUND Perioperative steroid protocols for patients undergoing transsphenoidal surgery (TSS) for pituitary pathology vary by institution. OBJECTIVE To assess the safety of withholding glucocorticoids in patients undergoing TSS. METHODS Patients with an intact hypothalamic-pituitary-adrenal (HPA) axis undergoing TSS for a pituitary tumor at the same academic institution between 2012 and 2015 were randomized to either receive 100 mg of intravenous hydrocortisone followed by 0.5 mg of intravenous dexamethasone every 6 h for 4 doses (STER, n = 23) or to undergo surgery without steroids (NOSTER, n = 20). Postoperative cortisol levels were then used to determine the need for glucocorticoids after surgery. Data regarding postoperative cortisol levels, hospital stay length, and complications were collected. RESULTS Mean postoperative 8 am cortisol levels were higher in the NOSTER group compared to the STER group (745 ± 359 nmol/L and 386 ± 193 nmol/L, respectively, P = .001) and more patients were discharged on glucocorticoids in the STER group (42% vs 12%, P = .07). There was no difference in the incidence of postoperative complications, including hyperglycemia, diabetes insipidus, or permanent adrenal insufficiency. Permanent adrenal insufficiency occurred in 8% of patients. CONCLUSION Perioperative steroids can be safely withheld in patients with an intact HPA axis undergoing TSS. Although administration of perioperative glucocorticoids does not appear to increase the risk of complications, it may interfere with assessment of the HPA axis after surgery.

scholarly journals Incidence of Central Diabetes Insipidus among the Patients Undergoing Pituitary Tumor Surgery through Trans-sphenoidal Approach

2019 ◽  
Vol 46 (2) ◽  
pp. 10-15
Author(s):  
KM Tarikul Islam ◽  
Shamsul Alam ◽  
Rezaul Amin ◽  
Haradhon Deb-nath ◽  
Mohammad Hossain ◽  
...  
Keyword(s):  
Diabetes Insipidus ◽  
Pituitary Tumor ◽  
Kidney Diseases ◽  
Operative Management ◽  
Central Diabetes Insipidus ◽  
Electrolyte Imbalance ◽  
P Value ◽  
Fisher Exact Test ◽  
Tumor Surgery ◽  
Microsurgical Approach

This study was carried out to find out the incidence of central diabetes insipidus (DI) among the patients undergoing pituitary tumor surgery through trans-sphenoidal approach either endoscopic or microsurgical for the first time. Patients with central (Neurogenic) diabetes insipidus prior to surgery, comorbidities like diabetes mellitus, kidney diseases, electrolyte imbalance, recurrent cases were excluded from this study. Patients were followed up to 7th postoperative day by recording and analyzing findings of postoperative serum electrolytes, urinary specific gravity, hourly urinary volume for establishing diabetes insipidus. 76.9% and 23.1% of patients developed diabetes insipidus those who underwent pituitary tumor surgery by trans-sphenoidal endoscopic approach and microsurgical approach respectively. 70% and 30% of patients did not develop diabetes insipidus those who underwent pituitary tumor surgery by trans-sphenoidal endoscopic and microsurgical approach respectively. There was no significant deference between the approaches were found. Fisher exact test was done and p-value was 0.712. Prediction of DI help us in pre-operative counseling and post-operative management of the patients as well as to reduce complications related morbidity after pituitary tumor surgery. Bangladesh Med J. 2017 May; 46 (2): 10-15

Sign in / Sign up

Export Citation Format

Share Document